Synovial Sarcoma (SySa) is genetically characterized by a specific reciprocal translocation t(X;18)(p11;q11), which has convincingly been defined as the major oncogenic driver of the disease, i.e., the SS18-SSX transcriptional dysregulator [1, 2, 51]. The gene discussed is SSX2; the disease is synovial sarcoma.